Common Stock Compensation

3 Months Ended

Sep. 30, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Common Stock Compensation

(11) Common Stock Compensation

Stock Option Activity Summary

The Company’s stock option activity for the three months ended September 30, 2020 is as follows:

	Shares (in thousands)			Weighted Average Exercise Price
Outstanding at June 30, 2020		325		$	5.68
Granted		—			—
Exercised		—			—
Canceled or expired		(1	)		5.30
Outstanding at September 30, 2020		324		$	5.68

The aggregate intrinsic value of options exercisable at September 30, 2020 was $0, as the fair value of the Company’s common stock is less than the exercise prices of these options. The remaining stock-based compensation expense of $2 thousand related to stock options will be recognized over a weighted-average period of 2.03 years.

The table below details the Company’s stock options outstanding as of September 30, 2020:

Range of exercise prices	Number Outstanding		Options Outstanding Weighted- Average Remaining Contractual Life (years)		Weighted- Average Exercise Price		Number Exercisable		Options Exercisable Weighted- Average Exercise Price
$1.85 – 3.55		76,500		2.53	$	3.43		66,500	$	3.43
$5.30 – 5.85		118,161		6.61		5.49		113,203		5.49
$6.00 – 8.35		130,000		4.14		7.19		86,000		6.59
$1.85 – 8.35		324,661		4.66	$	5.68		265,703	$	5.33

Compensation costs recognized related to stock option awards were $0 and $44 thousand for the three months ended September 30, 2020, and 2019, respectively.

Restricted Stock

The Company’s restricted stock activity for the three months ended September 30, 2020, is as follows:

	Shares (in thousands)			Weighted Average Grant-Date Fair Value
Outstanding at June 30, 2020		133		$	3.95
Granted		—			—
Vested		(1	)		2.47
Canceled or expired		(7	)		3.59
Outstanding at September 30, 2020		125		$	3.99

Stock compensation expenses related to restricted stock were $44 thousand and $60 thousand for the three months ended September 30, 2020, and 2019, respectively. The remaining stock-based compensation expense of $232 thousand related to restricted stock awards granted will be recognized over a weighted-average period of 1.23 years.